# Consensus checked against original sources: Mouth Taping and Obstructive Sleep Apnea

Cutoff: 13 October 2026. Consensus supports discovery and checks of specific source aspects; it is not a primary study, a full-paper audit or a causal probability meter.

## Porous-patch study design
The original is a thirty-person prospective before-during pilot. Its 35 percent median AHI change and sleepiness improvement are real reported findings, but no randomized concurrent control or anatomical-mediator necessity is established. [Original PMID25450408](https://pubmed.ncbi.nlm.nih.gov/25450408/). Access: abstract_metadata.

## Omitted direct tape pilot and original design
Consensus did not prominently retrieve Lee2022 despite the explicit brief. Its actual Methods identify retrospective tolerated-user selection and treatment of nasal obstruction; the AHI change cannot be described as a controlled prospective tape-only trial. [Original PMID36141367](https://pubmed.ncbi.nlm.nih.gov/36141367/). Access: full_text_partial.

## Puffing sample and responder grouping
The original abstract reports seventy-one participants and fixed usual-then-taped nights, with groups classified by measured ODI response. Provider wording using fifty-eight and a categorical adverse percentage is not adopted without matched body definitions. [Original PMID37032816](https://pubmed.ncbi.nlm.nih.gov/37032816/). Access: abstract_metadata.

## Sedated airflow and compensation
The original defines drug-induced sleep endoscopy and alternating-breath manual closure, with worse flow in high oral breathers. This is mechanistic safety-relevant evidence, not a natural-sleep tape-only AHI trial; a provider omission is not absence of the study. [Original PMID39361293](https://pubmed.ncbi.nlm.nih.gov/39361293/). Access: abstract_metadata.

## Randomized CPAP-adjunct outcome
The sixty-two-person trial reports more CPAP usage with adjunct tape. This controlled finding is retained without converting it into tape-alone treatment efficacy. [Original PMID40963295](https://pubmed.ncbi.nlm.nih.gov/40963295/). Access: abstract_metadata.

## Wearable endpoint specificity
The original finds high sleep sensitivity and limited wake specificity, mixed stages and worse disrupted-night performance. These are device-specific validation findings rather than a universal assertion that all wearable measurements are useless. [Original PMID33378539](https://pubmed.ncbi.nlm.nih.gov/33378539/). Access: abstract_metadata.

## Recent device validation
The original reports useful healthy-cohort agreement and device-specific stage biases. Blanket dismissal of all commercial stage estimates would ignore these distinctions. [Original PMID39460013](https://pubmed.ncbi.nlm.nih.gov/39460013/). Access: abstract_metadata.

## Multinight causal confounder
Measured night-to-night AHI variability gives a concrete reason to require repeated baseline and treatment nights. The large purchaser sample does not itself prove that pilot improvements are artifacts. [Original PMID34904935](https://pubmed.ncbi.nlm.nih.gov/34904935/). Access: abstract_metadata.

## Methods
Consensus was used to identify literature and cross-check specific claims about design, endpoints, scope and research gaps. Those aspects were checked against original primary abstracts/status records and selected original Methods/Results passages. Consensus output was not treated as original full text. Provider search omissions are not evidence that a study does not exist. Source access and examination receipts are retained. Scite use or monthly unavailability is recorded per case; provider citation counts do not change causal grades.